Type I and II metabotropic glutamate receptors regulate the outflow of [3H]D-aspartate and [14C]γ-aminobutyric acid in rat solitary nucleus

被引:13
作者
Jones, NM
Monn, JA
Beart, PM [1 ]
机构
[1] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
基金
澳大利亚研究理事会;
关键词
nucleus tractus solitarii; H-3]D-Aspartate; C-14]GABA (C-14]gamma-aminobutyric acid); outflow; in vitro; metabotropic glutamate receptor; superfusion;
D O I
10.1016/S0014-2999(98)00394-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabotropic glutamate (mGlu) receptors modulating amino acid outflow were examined in a model system in order to further characterize the pharmacological nature of the mGlu receptors involved in viscerosensory processing in the nucleus tractus solitarii. The actions of a number of subtype-selective mGlu receptor agonists and antagonists were monitored on the K+-evoked outflow of [H-3]D-aspartate and [C-14]gamma-aminobutyric acid (GABA) from superfused slices of rat nucleus tractus solitarii. (+/-)1S,3R-1-Amino-cyclopentane-1,3-dicarboxylate (10-300 mu M), produced a concentration-dependent increase in outflow, which was attenuated by a number of phenylglycine antagonists. (2S,3S,4S)-alpha-(Carboxycyclopropyl)-glycine (30-300 mu M) had mixed effects on outflow. The type I-selective agonist (RS)-3,5-dihydroxyphenylglycine (300 mu M) also increased outflow and these effects were reversed by the type I antagonist (RS)-1-aminoindan-1,5-dicarboxylate (100 mu M). Activation of type II mGlu receptors with (2 R,4R)-aminopyrrolidine-2,4-dicarboxylate (300 mu M), however, decreased outflow, and this effect was antagonized by the type II antagonist LY307452 (200 mu M). Interestingly, LY307452 (200 mu M) alone, enhanced outflow of [H-3]D-aspartate, but not [C-14]GABA. Type III mGlu receptors may not be involved in outflow of [H-3]D-aspartate and [C-14]GABA in the nucleus tractus solitarii, as L-2-amino-4-phosphonobutyrate (30-300 mu M) had no effect under the present experimental conditions. These in vitro studies provide new evidence for roles for Type I and II mGlu receptors in viscerosensory processing in nucleus tractus solitarii. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 47 条
[1]  
Arai I, 1996, BRAIN RES, V729, P277, DOI 10.1016/S0006-8993(96)00581-1
[2]   SIGNAL TRANSDUCTION AND PHARMACOLOGICAL CHARACTERISTICS OF A METABOTROPIC GLUTAMATE RECEPTOR, MGLUR1, IN TRANSFECTED CHO CELLS [J].
ARAMORI, I ;
NAKANISHI, S .
NEURON, 1992, 8 (04) :757-765
[3]   EXCITATORY AMINO-ACID PROJECTIONS TO THE NUCLEUS OF THE SOLITARY TRACT IN THE RAT - A RETROGRADE TRANSPORT STUDY UTILIZING D-[H-3]ASPARTATE AND [H-3] GABA [J].
BEART, PM ;
SUMMERS, RJ ;
STEPHENSON, JA ;
CHRISTIE, MJ .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1994, 50 (01) :109-122
[4]   NEUROCHEMICAL STUDIES OF THE MESOLIMBIC DOPAMINERGIC PATHWAY - SOMATODENDRITIC MECHANISMS AND GABAERGIC NEURONS IN THE RAT VENTRAL TEGMENTUM [J].
BEART, PM ;
MCDONALD, D .
JOURNAL OF NEUROCHEMISTRY, 1980, 34 (06) :1622-1629
[5]   PHENYLGLYCINE DERIVATIVES DISCRIMINATE BETWEEN MGLUR1-MEDIATED AND MGLUR5-MEDIATED RESPONSES [J].
BRABET, I ;
MARY, S ;
BOCKAERT, J ;
PIN, JP .
NEUROPHARMACOLOGY, 1995, 34 (08) :895-903
[6]   CENTRAL CONTROL OF BLOOD-PRESSURE [J].
CHALMERS, JP ;
KAPOOR, V ;
LLEWELLYNSMITH, IJ ;
MINSON, JB ;
PILOWSKY, PM .
EUROPEAN HEART JOURNAL, 1992, 13 :2-9
[7]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[8]   METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS INHIBIT ENDOGENOUS GLUTAMATE RELEASE FROM RAT STRIATAL SYNAPTOSOMES [J].
EAST, SJ ;
HILL, MP ;
BROTCHIE, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 277 (01) :117-121
[9]  
GIEROBA ZJ, 1993, N-S ARCH PHARMACOL, V347, P66
[10]   THE ACTIONS OF PHENYLGLYCINE DERIVED METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONISTS ON MULTIPLE (1S,3R)-ACPD RESPONSES IN THE RAT NUCLEUS OF THE TRACTUS-SOLITARIUS [J].
GLAUM, SR ;
SUNTER, DC ;
UDVARHELYI, PM ;
WATKINS, JC ;
MILLER, RJ .
NEUROPHARMACOLOGY, 1993, 32 (12) :1419-1425